Kreis Leslie W.'s Form 4 filing
Cognition Therapeutics Inc (CGTX) · filed Nov 16, 2022
- Accession no.
- 0001104659-22-119339
- Filed
- Nov 16, 2022, 6:59 AM ET
- Trade date
- Nov 15, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.80M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kreis Leslie W.CIK 0001813316 | Director |
| BIOS Memory SPV II, LPCIK 0001666485 | 10% Owner |
| BIOS Fund II NT, LPCIK 0001728851 | 10% Owner |
| BIOS Fund III NT, LPCIK 0001791910 | 10% Owner |
| BIOS Fund III QP, LPCIK 0001791916 | 10% Owner |
| BIOS Fund III, LPCIK 0001791917 | 10% Owner |
| Cavu Management, LPCIK 0001813270 | 10% Owner |
| Cavu Advisors, LLCCIK 0001813310 | 10% Owner |
| BIOS Equity Partners III, LPCIK 0001831976 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | Common Stock | PPurchaseAcquired | +184,270 | $1.20 | +$221,124 | 316,038 | Indirect | |
| Nov 15, 2022 | Common Stock | PPurchaseAcquired | +1,141,030 | $1.20 | +$1,369,236 | 1,955,677 | Indirect | |
| Nov 15, 2022 | Common Stock | PPurchaseAcquired | +174,700 | $1.20 | +$209,640 | 299,608 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.